- Home
- PMTS vs BNTC Comparison
PMTS vs BNTC Comparison
Compare PMTS & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- BNTC
- Stock Information
- Founded
- PMTS 2007
- BNTC 1995
- Country
- PMTS United States
- BNTC United States
- Employees
- PMTS N/A
- BNTC N/A
- Industry
- PMTS Finance Companies
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- PMTS Finance
- BNTC Health Care
- Exchange
- PMTS Nasdaq
- BNTC Nasdaq
- Market Cap
- PMTS 316.9M
- BNTC 339.8M
- IPO Year
- PMTS 2015
- BNTC N/A
- Fundamental
- Price
- PMTS $28.27
- BNTC $15.30
- Analyst Decision
- PMTS Strong Buy
- BNTC Strong Buy
- Analyst Count
- PMTS 5
- BNTC 7
- Target Price
- PMTS $34.40
- BNTC $24.43
- AVG Volume (30 Days)
- PMTS 35.9K
- BNTC 34.2K
- Earning Date
- PMTS 03-04-2025
- BNTC 05-12-2025
- Dividend Yield
- PMTS N/A
- BNTC N/A
- EPS Growth
- PMTS N/A
- BNTC N/A
- EPS
- PMTS 1.64
- BNTC N/A
- Revenue
- PMTS $480,601,000.00
- BNTC N/A
- Revenue This Year
- PMTS $8.62
- BNTC N/A
- Revenue Next Year
- PMTS $7.15
- BNTC N/A
- P/E Ratio
- PMTS $17.63
- BNTC N/A
- Revenue Growth
- PMTS 8.11
- BNTC N/A
- 52 Week Low
- PMTS $15.21
- BNTC $4.75
- 52 Week High
- PMTS $35.19
- BNTC $15.97
- Technical
- Relative Strength Index (RSI)
- PMTS 51.24
- BNTC 71.12
- Support Level
- PMTS $27.57
- BNTC $11.99
- Resistance Level
- PMTS $31.85
- BNTC $15.97
- Average True Range (ATR)
- PMTS 1.92
- BNTC 1.00
- MACD
- PMTS -0.17
- BNTC 0.33
- Stochastic Oscillator
- PMTS 37.79
- BNTC 85.67
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.